University of Iowa Research Foundation

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

UIRF’s relationship with the University of Iowa is directed by the University of Iowa Intellectual Property Policy.

The UIRF’s primary functions are:

  • Licensing - finding suitable partners for commercializing UI technologies and inventions
  • New Ventures - identifying and developing new high growth UI technology spinout companies suitable for venture capital financing
  • Intellectual property services - which include protecting UI inventions through patents and copyrights, advising on intellectual property terms for Clinical Trials and Sponsored Research, and executing out-going material transfers

Our Mission

The UIRF’s mission is to:

  • Champion the commercialization of selected UI inventions for public benefit and for return on investment
  • Catalyze economic development and an entrepreneurial culture in Iowa
  • Build the vitality and sustainability of the University and the community through technology commercialization
  • Serve the research mission for continued innovation

Our Vision

The UIRF aspires to maximize public benefit through commercial use of UI technologies, excellence in commercialization, and long term sustainability.

Recently Issued Patents

US 9,211,347
(12/15/2015)

Method of Delivering Vectors to Pancreas and Lungs by Cannulating the Aorta

US 9,193,777
(11/24/2015)

Method of Treating Cardiac Arrhythmia with Long Acting Atrial Natriuretic Peptide (LA-ANP)

US 9,192,633
(11/24/2015)

Use of Parasitic Biological Agents for Disease Prevention and Control

US 9,181,544
(11/10/2015)

Therapeutic Compounds

US 9,181,291
(11/10/2015)

Tannin Inhibitors of HIV

US 9,169,483
(10/27/2015)

RNA Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof

US 9,168,307
(10/27/2015)

Mitochondrial-targeted Cationic Nanoparticles Comprising CaMKII Inhibitors and Uses Thereof for Treating and Preventing Diseases and Disorders Associated with CaMKII Activity

US 9,139,835
(9/22/2015)

Nucleic Acid Aptamers

US 9,125,967
(9/8/2015)

Fluorapatite Glass-ceramics

US 9,119,957
(9/1/2015)

Cochlear Implant System Component Having Multiple Electrode Assemblies

US 9,090,701
(7/28/2015)

Methods of Detecting Oxidized Calcium/calmodulin Dependent Protein Kinase II

US 9,063,139
(6/23/2015)

Variants in Complement Regulatory Genes Predict Age-related Macular Degeneration

US 9,063,118
(6/23/2015)

Isolation and Characterization of Tumor Cells Using Shear Stress Measurements

address: 112 N. Capitol Street, Iowa City, IA 52242     phone: 319-335-4546 fax: 319-335-4486 © University of Iowa 2015. All rights reserved.